# Filing Detail

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001075880-13-000023
Filing Date
2013-02-28
Accepted
2013-02-28 08:15:50
Documents
8
Period of Report
2013-02-28

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | CONVERTED BY EDGARWIZ | form6kproforma.htm | 6-K | 7255
2 | CONVERTED BY EDGARWIZ | novogenltd4d311212finalsigne.htm | EX-99 | 258455
3 | IMAGE | novogenltd4d311212finalsi001.jpg | GRAPHIC | 12879
4 | IMAGE | page4.jpg | GRAPHIC | 139741
5 | IMAGE | page5.jpg | GRAPHIC | 84294
6 | IMAGE | page21.jpg | GRAPHIC | 74411
7 | IMAGE | page22.jpg | GRAPHIC | 186365
8 | IMAGE | page23.jpg | GRAPHIC | 139600
| Complete submission text file | 0001075880-13-000023.txt |  | 1145577

Mailing Address LEVEL 1 1 - 7 WATERLOO ROAD NORTH RYDE NSW C3 2113
Business Address LEVEL 1 1 - 7 WATERLOO ROAD NORTH RYDE NSW C3 2113 01161298780088
NOVOGEN LTD (Filer) CIK: 0001075880 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 000-29962 | Film No.: 13649137
SIC: 2834 Pharmaceutical Preparations